Skip to Content
Merck

01042

N-Acetyl-L-cysteine methyl ester

≥90% (HPLC)

Synonym(s):

N-acetyl-L-cysteine methyl ester

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C6H11NO3S
CAS Number:
Molecular Weight:
177.22
NACRES:
NA.22
PubChem Substance ID:
eCl@ss:
32160406
UNSPSC Code:
12352209
MDL number:
Beilstein/REAXYS Number:
1724357
Assay:
≥90% (HPLC)
Form:
powder or crystals
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Level

assay

≥90% (HPLC)

form

powder or crystals

optical activity

[α]20/D −24.0±3°, c = 1% in methanol

reaction suitability

reaction type: solution phase peptide synthesis

color

white to faint yellow

mp

77-81 °C

application(s)

peptide synthesis

SMILES string

COC(=O)[C@H](CS)NC(C)=O

InChI

1S/C6H11NO3S/c1-4(8)7-5(3-11)6(9)10-2/h5,11H,3H2,1-2H3,(H,7,8)/t5-/m0/s1

InChI key

QTKAQJWFVXPIFV-YFKPBYRVSA-N

Other Notes

Sulfur transfer agent


Storage Class

11 - Combustible Solids

wgk

WGK 3

ppe

Eyeshields, Gloves, type N95 (US)

flash_point_f

No data available

flash_point_c

No data available



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



A. Gilman et al.
Tetrahedron Letters, 33, 1751-1751 (1993)
Renu A Kowluru et al.
Laboratory investigation; a journal of technical methods and pathology, 96(10), 1040-1049 (2016-07-28)
Diabetes elevates matrix metalloproteinase-9 (MMP-9) in the retina and its capillary cells, and activated MMP-9 damages mitochondria, accelerating retinal capillary cell apoptosis, a phenomenon which precedes the development of retinopathy. Diabetes also favors epigenetic modifications regulating the expression of many
Shinji Hatakeyama et al.
Skeletal muscle, 6, 26-26 (2016-07-28)
Cachexia affects the majority of patients with advanced cancer and is associated with reduced treatment tolerance, response to therapy, quality of life, and life expectancy. Cachectic patients with advanced cancer often receive anti-cancer therapies against their specific cancer type as



Global Trade Item Number

SKUGTIN
I11704-25G04061833847527
I11704-5G04061833361245
01042-5G04061832640938